Following a nationwide search, the University of Arizona has appointed Dr. Keith A. Joiner, as dean of the UA College of Medicine. Joiner, 55, is professor of medicine, cell biology and epidemiology, chief of the section of infectious diseases, and associate chairman of the department of medicine at the Yale University School of Medicine.
Joiner also serves as director of Yale's Investigative Medicine Program, which provides doctoral training in clinical investigation for physicians interested in either clinical or laboratory research. In addition to many other honors and awards, he is an elected member of the Association of American Physicians (AAP), the American Society for Clinical Investigation (ASCI), and a fellow of the American Association for the Advancement of Science (AAAS). He also is Yale's Waldemar von Zedtwitz Professor of Medicine.
Joiner will begin his new duties at the UA March 1, 2004. He replaces Dr. Kenneth Ryan, who has served as interim dean of the College of Medicine since July 2002.
Dr. Raymond Woosley, UA vice president for health sciences, said, "We are extremely fortunate Dr. Keith Joiner has agreed to serve as dean of our College of Medicine. He is a noted physician, research scientist and administrator who also has extensive health care administration skills. As our campus begins a major expansion project -- which includes the Thomas Keating Bioresearch Institute, the Medical Research Building and other major projects -- Dr. Joiner will provide the leadership to ensure the College of Medicine advances to new heights. He also will help expand our educational, research and service programs in the Greater Phoenix area.""Dr. Keith Joiner represents an outstanding opportunity for the University of Arizona and for AHSC in particular," said George H. Davis, UA executive vice president and provost. "He comes from an internationally distinguished program and he brings to us deep experience as a physician, researcher and academic medicine leader."
An accomplished physician-scientist, Joiner and his laboratory team at Yale are studying two specific parasites, one of which causes focal nervous system infections in AIDS patients (Toxoplasma gondi); another that causes malaria, resulting in 2 million deaths a year (Plasmodium falciparum). His research seeks to identify unique parasite targets for therapeutic intervention. He is the principal investigator on four grants from the National Institutes of Health, a recipient of the Burroughs Wellcome Fund New Initiatives in Malaria Research award, and is an Ellison Foundation Senior Scholar in Global Infectious Diseases.
Joiner earned his bachelor's degree, with honors, from the University of Chicago, 1970; his doctorate, cum laude, from the University of Colorado, 1974; and his master's degree in health policy and administration, Yale University School of Medicine, 2003, with a focus on optimizing resource allocation in academic health centers. He served his internship in Medicine at Royal Victoria Hospital, McGill University, Montreal. He was a junior assistant resident in Medicine, Royal Victoria Hospital, 1975-76; he was senior assistant resident in medicine, Mary Hitchcock Memorial Hospital, Dartmouth Medical School, Hanover, N.H., 1976-77. He completed his Infectious Diseases fellowship training at Tufts-New England Medical Center, Boston, 1977-80.
Joiner was a senior investigator in the Laboratory of Clinical Investigation, National Institutes of Health, Bethesda, Md., 1980-87. He headed the Unit of Microbial Pathogenesis in the Laboratory of Parasitic Diseases from 1987-89. He moved to Yale University School of Medicine in 1989 to assume his current role as Chief of the Section of Infectious Diseases.
Board certified in internal medicine and infectious diseases by the American Board of Internal Medicine, Joiner oversees an infectious disease section at Yale with 21 full-time faculty members and 11 clinical and research fellows.
Joiner is monitoring editor of the Journal of Cell Biology; he is on the editorial boards of Cellular Microbiology, Current Drug Targets Infectious Disorders and Parasite Cell Biology. He has authored or co-authored more than 200 scientific articles and has been invited to lecture at institutions throughout the world.
He holds two patents one as co-inventor of a quantitative assay for human terminal complement cascade and one as co-inventor for a method for treating gram positive septicemia.
Founded in 1967, the UA College of Medicine is known nationally for its many innovative teaching, clinical training and research programs. The College of Medicine is part of the University of Arizona Health Sciences Center (AHSC), which also includes the UA Colleges of Nursing and Pharmacy; the Mel and Enid Zuckerman Arizona College of Public Health; University Medical Center and The University Physicians.